Latest filing published 05 May 2008 for HAEMONETICS CORP, €7,069.
Insider track record
No signal scores available.
Closed purchases
Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -7.1%Entry US$27.49 · Close at T+365 US$25.52
- -1.5%Entry US$28.30 · Close at T+365 US$27.89
- +8.5%Entry US$24.80 · Close at T+365 US$26.91
- +26.7%Entry US$22.55 · Close at T+365 US$28.57
- -3.2%Entry US$25.78 · Close at T+365 US$24.97
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Mark A. Popovsky: trading record in brief
Mark A. Popovsky discloses dealings in Haemonetics Corp to SEC (Form 4). In total, 19 filings cover trades dated from 2 February 2006 to 1 May 2008.
Market trades split into 6 purchases (€46k) and 6 sales (€1.6M). The net balance comes to €1.6M on the selling side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 1 share grant and 6 option exercises. Since January 2008: 1 purchase and 2 sales on the market.
The median purchase comes to €7,574. After 5 purchases with a full 90-day history, the hit rate stands at 60% and the median 90-day move at +1.0%. These figures describe past trades and do not predict future prices.
The newest entry dates from 5 May 2008: an open-market purchase of €7,069, in Haemonetics Corp. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Mark A. Popovsky
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 246 shares@ US$44.35Common StockSEC:0000313143-08-000018:0Canonical exit: 30 Jul 2008 (T+90)
- 5,000 shares@ US$31.66Common StockSEC:0000313143-08-000001:0
- 5,000 shares@ US$61.98Common StockSEC:0000313143-08-000001:1
- 5,000 shares@ US$26.11Common StockSEC:0000313143-08-000001:2
- 253 shares@ US$40.66Common StockSEC:0000313143-07-000056:0Canonical exit: 30 Jan 2008 (T+90)
- 840 shares@ US$0.01Common StockSEC:0000313143-07-000046:0
- 7,000 shares@ US$22.72Common StockSEC:0000313143-07-000034:0
- 7,000 shares@ US$52.79Common StockSEC:0000313143-07-000034:1
- 282 shares@ US$38.63Common StockSEC:0000313143-07-000024:0Canonical exit: 30 Jul 2007 (T+90)
- 7,000 shares@ US$22.72Common StockSEC:0000313143-07-000017:0
- 7,000 shares@ US$48.00Common StockSEC:0000313143-07-000017:1
- 10,000 shares@ US$22.72Common StockSEC:0000313143-07-000009:0
- 10,000 shares@ US$47.79Common StockSEC:0000313143-07-000009:1
- 228 shares@ US$38.76Common StockSEC:0000313143-06-000126:0Canonical exit: 30 Jan 2007 (T+90)
- 258 shares@ US$41.52Common StockSEC:0000313143-06-000030:0Canonical exit: 30 Jul 2006 (T+90)
- 7,000 shares@ US$22.72Common StockSEC:0000313143-06-000008:0
- 7,000 shares@ US$50.20Common StockSEC:0000313143-06-000008:1
17 of 17 declarations
